Unknown NA INTERVENTIONAL 1-arm NCT04329689

Hyp Obst Cardiomyopathy

Hypertrophic ObsructiveCardiomyopathy:Should the Mitral Valve be Addressed During Septal Myectomy?

Sponsor: Assiut University

Conditions Hypertrophic Obstructive Cardiomyopathy

Updated 5 times since 2020 Last updated: Mar 30, 2020 Started: May 1, 2020 Primary completion: May 1, 2022 Completion: Jun 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04329689, this NA trial focuses on Hypertrophic Obstructive Cardiomyopathy and remains ongoing. Sponsored by Assiut University, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jul 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jul 2022 [monthly]

Not Yet Recruiting NA
May 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.